A bill for an act prohibiting certain actions relating to abortifacient drugs in the state, and providing penalties.

2025-2026 Regular Session

HF 423 bans certain abortifacient drug actions in the state with penalties; clarifies contraception before conception remains allowed.

Introduced, referred to Health and Human Services.

#abortifacients #abortions #prescriptiondrugs

Overview

HF 423 is a proposed bill introduced in the state legislature and referred to Health and Human Services. Its stated purpose is to prohibit certain actions relating to abortifacient drugs within the state and to provide penalties. The text also includes a clarifying provision related to contraception administered before conception.

Bill number: HF 423

Title: A bill for an act prohibiting certain actions relating to abortifacient drugs in the state, and providing penalties

Status: Introduced; referred to Health and Human Services

Introduced: February 17, 2025

Subject: Abortifacients, Abortions, Prescription Drugs

Purpose and Scope

The central aim is to prohibit certain actions involving abortifacient drugs (drugs used to terminate a pregnancy) within the state.

The bill also intends to impose penalties for violations.

A clarifying provision states that the bill should not be construed to prohibit the sale, use, prescription, or administration of any contraceptive agent administered prior to conception or before a pregnancy can be confirmed through conventional medical testing.

Key Provisions (as reflected in the introduced text)

Prohibition on certain actions related to abortifacient drugs within the state. The exact actions prohibited are not fully enumerated in the provided excerpt, but the bill’s purpose centers on restricting abortifacient drug activity.

Exemption/clarification for contraception: The bill explicitly allows continued sale, use, prescription, or administration of contraceptive agents before conception or before pregnancy confirmation by conventional medical testing.

Conforming changes: The bill includes a conforming change to state law (Code) to remove or eliminate a reference to an abortifacient drug that would be prohibited under the bill.

Penalties: The bill provides for penalties related to violations, though the specific penalty structure (e.g., fines, enforcement mechanisms) is not detailed in the excerpt available.

Affected Parties

Providers, pharmacists, and other healthcare professionals involved in prescribing, dispensing, or administering abortifacient drugs would be subject to the prohibitions and penalties.

Patients seeking abortifacient medications could be affected by the prohibitions.

Entities involved in the sale and distribution of abortifacient drugs may also be impacted.

Contraceptive services that occur before conception appear to be exempt from prohibition under the bill’s clarifying language.

Procedural and Timeline Aspects

Introduced on February 17, 2025 and referred to the Health and Human Services committee.

As with most introduced bills, subsequent steps would include committee consideration, potential amendments, floor votes, and, if enacted, eventual signing into law and publication of effective dates. None of these steps are specified in the provided text.

Observations and Notes

The available text is partial. Details on the exact definitions of “abortifacient drugs,” the scope of prohibited actions, and the precise penalties are not provided here.

The clarifying language on contraception indicates an intent to avoid restricting standard contraceptive practices that occur before pregnancy.

If you’d like, I can tailor this summary to emphasize specific sections (e.g., penalties, affected entities) or compare HF 423 to existing state laws on abortifacient drugs once the full text is available.

Bill